These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7487142)
1. FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Furukawa F; Imamura S; Takigawa M Arch Dermatol Res; 1995; 287(6):558-63. PubMed ID: 7487142 [TBL] [Abstract][Full Text] [Related]
2. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice. Entani C; Izumino K; Iida H; Fujita M; Asaka M; Takata M; Sasayama S Nephron; 1993; 64(3):471-5. PubMed ID: 7688103 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp- +/+ mice. Furukawa F; Ohshio G; Imamura S Arch Dermatol Res; 1993; 285(1-2):20-6. PubMed ID: 8470930 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Japanese-Chinese herbal medicine, kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. Kanauchi H; Imamura S; Takigawa M; Furukawa F J Dermatol; 1994 Dec; 21(12):935-9. PubMed ID: 7868765 [TBL] [Abstract][Full Text] [Related]
6. CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production. Shi L; Bian Z; Chen CX; Guo YN; Lv Z; Zeng C; Liu Z; Zen K; Liu Y J Pathol; 2015 Nov; 237(3):285-95. PubMed ID: 26095930 [TBL] [Abstract][Full Text] [Related]
7. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice. Yang J; Li Q; Yang X; Li M Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303 [TBL] [Abstract][Full Text] [Related]
9. Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice. Woo J; Wright TM; Lemster B; Borochovitz D; Nalesnik MA; Thomson AW Clin Exp Immunol; 1995 Apr; 100(1):118-25. PubMed ID: 7535208 [TBL] [Abstract][Full Text] [Related]
10. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan. Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825 [TBL] [Abstract][Full Text] [Related]
11. Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506. Yamamoto K; Mori A; Nakahama T; Ito M; Okudaira H; Miyamoto T Immunology; 1990 Feb; 69(2):222-7. PubMed ID: 1689694 [TBL] [Abstract][Full Text] [Related]
12. Involvement in lupus disease of idiotypes Id.F-423 and Id.IV-228 defined, respectively, upon foetal and adult MRL/Mp-lpr/lpr DNA-binding monoclonal autoantibodies. Ravirajan CT; Staines NA Immunology; 1991 Oct; 74(2):342-7. PubMed ID: 1748483 [TBL] [Abstract][Full Text] [Related]
13. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859 [TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome in mice carrying the Ipr(cg) gene and the therapeutic efficacy of an immunosuppressive agent FK506. Yang J; Shikata N; Yasuda T; Matsuzawa A; Tsubura A Pathol Int; 1999 Feb; 49(2):133-40. PubMed ID: 10355966 [TBL] [Abstract][Full Text] [Related]
15. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog. Choi JY; Gao W; Odegard J; Shiah HS; Kashgarian M; McNiff JM; Baker DC; Cheng YC; Craft J Arthritis Rheum; 2006 Oct; 54(10):3277-83. PubMed ID: 17009262 [TBL] [Abstract][Full Text] [Related]
16. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice. Iwata Y; Wada T; Furuichi K; Sakai N; Matsushima K; Yokoyama H; Kobayashi K J Am Soc Nephrol; 2003 Jan; 14(1):57-67. PubMed ID: 12506138 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of autoimmune deterioration in MRL/lpr mice by vitamin E. Weimann BJ; Hermann D Int J Vitam Nutr Res; 1999 Jul; 69(4):255-61. PubMed ID: 10450530 [TBL] [Abstract][Full Text] [Related]
18. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/ Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505 [TBL] [Abstract][Full Text] [Related]
19. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144 [TBL] [Abstract][Full Text] [Related]
20. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Walker SL; Kirby B; Chalmers RJ Br J Dermatol; 2002 Aug; 147(2):405-6. PubMed ID: 12174136 [No Abstract] [Full Text] [Related] [Next] [New Search]